VideoHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Evaluating the integration of telehealth during COVID-19 in Bangkok - Sorawit AmataveteView Video
VideoHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021A high retention rate among TelePrEP users for HIV Pre-exposure Prophylaxis in Japan - S. DaisukeView Video
DTTDoan Thanh TungBAVideoHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Impact of the Syndemic(s) - Community Perspective - Doan Thanh Tung, BAView Video
CSCarol StrongPhD, MPHVideoHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Syndemics of Mental Health Issues and Chemsex - Carol Strong, PhD, MPHView Video
KRKane RaceBA (Hons), LLB, PhDVideoHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Importance of Cultural and Social Understanding of Chemsex in the HIV Response - K. Race, BA (Hons)View Video
LWLinfa WangPhD, FTSEVideoHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Virology of SARS-CoV-2 - Linfa Wang, PhD, FTSEView Video
SLSharon LewinAO, FRACP, PhD, FAHMSSlidesetHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Update on COVID-19 Vaccines - What’s Available and What's the Future S. Lewin, AO, FRACP, PhD, FAHMSView Slideset
YJLYing-Ru Jacqueline LoMDSlidesetHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021The COVAX Facility - Fair and Equitable Access to COVID-19 Vaccines - Y. Lo, MDView Slideset
NPNittaya PhanuphakMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Translating the Science of Long-acting PrEP into Implementation - N. Phanuphak, MD, PhDView Slideset
RMGRoy M. GulickMD, MPHSlidesetHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Positioning Long-acting ARV in LMIC - R. Gulick, MD, MPHView Slideset
RMGRoy M. GulickMD, MPHSlidesetHIVRSVViral Hepatitis and Liver DiseaseTuberculosisAPACC 2021Positioning Long-acting ARV in LMIC - R. Gulick, MD, MPHView Slideset
WSWai-Kay SetoMBBS, MD, MRCP, FRCP, FHKCP, FHKAM, AGAFSlidesetHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Prevention and Monitoring Strategies for HCC in HBV Patients - W. Seto, MBBS, MD, MRCP, FRCP, FHKCP, FHKAM, AGAFView Slideset
